Ceva Swine Team conduct latest symposium >
Actinobacillus pleuropneumoniae: the latest scientific research applied to field control strategies.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Dr. Steve Chu joins Ceva after 25 years at Fort Dodge and Elanco >
Addition to talented team positions Ceva for continued growth.
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva re-enforces expertise in freeze-drying with completion of € 2.8m plant >
Ceva Santé Animale intends to use the new freeze-drying facility to increase its toll-manufacturing activity.
Ceva conducts latest of its Expert Symposia >
Veterinary specialists gather in Madrid to discuss latest trends in sow reproduction
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.
Ceva adopts new logo >
Following the success of its first 10 year plan, Ceva sets out its vision to create value beyond animal health.
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquire a majority share of Sumitomo’s animal health subsidiary, Summit VetPharm, LLC. Sumitomo Corporation will remain a minority shareholder in the new North American CEVA companion animal business, which...